Literature DB >> 27493600

The Role of Bariatric Surgery in the Management of Nonalcoholic Steatohepatitis.

Joseph K Lim1.   

Abstract

Entities:  

Year:  2016        PMID： 27493600      PMCID： PMC4971823     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

Review 2.  The impact of bariatric surgery on nonalcoholic steatohepatitis.

Authors:  Charlotte Rabl; Guilherme M Campos
Journal:  Semin Liver Dis       Date:  2012-03-13       Impact factor: 6.115

3.  Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.

Authors:  Guillaume Lassailly; Robert Caiazzo; David Buob; Marie Pigeyre; Hélène Verkindt; Julien Labreuche; Violeta Raverdy; Emmanuelle Leteurtre; Sébastien Dharancy; Alexandre Louvet; Monique Romon; Alain Duhamel; François Pattou; Philippe Mathurin
Journal:  Gastroenterology       Date:  2015-04-25       Impact factor: 22.682

Review 4.  Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss.

Authors:  Violeta B Popov; Joseph K Lim
Journal:  J Clin Transl Hepatol       Date:  2015-09-15
  4 in total
  1 in total

Review 1.  Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.

Authors:  Antonella Borrelli; Patrizia Bonelli; Franca Maria Tuccillo; Ira D Goldfine; Joseph L Evans; Franco Maria Buonaguro; Aldo Mancini
Journal:  Redox Biol       Date:  2018-02-03       Impact factor: 11.799
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.